CBD FORMULATIONS AND USES THEREOF
Last updated:
Abstract:
Provided herein are formulations including a cannabinoid and N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester (APM). Also provided are methods of using the formulations.
Status:
Application
Type:
Utility
Filling date:
7 Aug 2020
Issue date:
11 Feb 2021